FDA pharmacologic class

Epidermal Growth Factor Receptor Antagonist

2 medicines are in FDA's class of epidermal growth factor receptor antagonists: cetuximab (Erbitux) and panitumumab (Vectibix). 0 of the 2 are listed from generic labelers (FDA NDC Directory, October 8, 2026).

Which medicines are epidermal growth factor receptor antagonist?

Recalls: FDA enforcement reports, 2012 on
Medicine	Brand names	Generic labelers (all forms)	Pharmacy cost	Boxed warning	Shortage	Recalls since 2012
Cetuximab	Erbitux	none listed	n/a	Yes	No current entry	2
Panitumumab	Vectibix	none listed	n/a	Yes	No current entry	1

Source: FDA Established Pharmacologic Class (NDC Directory, openFDA); CMS NADAC of October 7, 2026; FDA shortages and recalls (FDA files October 8, 2026)

What next?

Every drug class
Medicines A to Z